Eğitim Bilgileri
2009 - 2013
2009 - 2013Tıpta Yandal Uzmanlık
İstanbul Üniversitesi, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı, Türkiye
2002 - 2008
2002 - 2008Tıpta Uzmanlık
İstanbul Üniversitesi, İstanbul Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Akademik Unvanlar / Görevler
2015 - Devam Ediyor
2015 - Devam EdiyorDoç. Dr.
Acıbadem Mehmet Ali Aydınlar Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2014 - 2015
2014 - 2015Yrd. Doç. Dr.
Fırat Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorStaj Koordinatörü
Acıbadem Mehmet Ali Aydınlar Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Verdiği Dersler
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
2024
2024Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer
Fahy M., Kelly M. E., Abecasis N., Akhtar S. N., Akiyoshi T., Alvarez-Gallego M., et al.
COLORECTAL DISEASE
, sa.5, ss.926-931, 2024 (SCI-Expanded)
2024
2024Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study
ÖLMEZ Ö. F., BİLİCİ A., ER Ö., BİŞGİN A., Sevinc A., Akman T., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
, sa.5, ss.562-568, 2024 (SCI-Expanded)
2023
2023Case Report: Chemoimmunotherapy in microsatellite-instability-high advanced goblet cell carcinoma of the colon
Mutlu A. U., Aytaç E., Gulmez M., Erdamar Çetin A. S., Ozer L.
FRONTIERS IN IMMUNOLOGY
, 2023 (SCI-Expanded)
2023
2023Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1–2 cm
Aktas M. K., AYTAÇ E., YILDIZ İ., OZER L.
The Lancet Oncology
, cilt.24, sa.5, 2023 (SCI-Expanded)
2023
2023Current trends in perioperative treatment of resectable gastric cancer.
Yıldız İ., Özer L., Şenocak Taşçı E., Bayoglu İ. V., Aytac E.
World journal of gastrointestinal surgery
, cilt.15, sa.3, ss.323-337, 2023 (SCI-Expanded)
2022
2022Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement
Aytaç E., Özer L., Baca B., Balık E., Kapran Y., Taşkın O. C., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.8, ss.627-663, 2022 (SCI-Expanded)
2022
2022Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Tasci E. S., Oyan B., Sonmez Ö., Mutlu A. U., Atci M. M., Oner I., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.40, sa.4, 2022 (SCI-Expanded)
2022
2022Intramural Component of Venous, Lymphatic, and Perineural Invasion in Colon Cancer: A Threat or an Illusion?
Özer L., Taşçı E. Ş., Mutlu A. U., Piyade B., Ramoğlu N., Ajredini M., et al.
BALKAN MEDICAL JOURNAL
, cilt.39, sa.6, ss.436-443, 2022 (SCI-Expanded)
2021
2021Clinicopathological and Prognostic Significance of MSI Status and PD-L1 Expression in Turkish Patients with Gastric Cancer
Bahsi S., YILDIZ İ., Erdamar S., Goksel S., Tozun N., AYTAÇ E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.31, sa.4, ss.246-254, 2021 (SCI-Expanded)
2019
2019Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group
AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, sa.7, ss.584-598, 2019 (SCI-Expanded)
2019
2019The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma
TUNÇER Ş. B., AKDENİZ ÖDEMİŞ D., ÇELİK B., KILIÇ ERCİYAS S., Sukruoglu O., Avsar M., et al.
MOLECULAR BIOLOGY REPORTS
, cilt.46, sa.1, ss.975-980, 2019 (SCI-Expanded)
2018
2018Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy.
Yildiz İ., Bilici A., Karadurmus N., Ozer L., Tural D., Kaplan M. A., et al.
Tumori
, cilt.104, sa.6, ss.444-450, 2018 (SCI-Expanded)
2017
2017Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience.
Kılıç L., Ekenel M., Karabulut S., Ağaoğlu F., Darendeliler E.
Contemporary oncology (Poznan, Poland)
, cilt.21, ss.60-65, 2017 (SCI-Expanded)
2016
2016Clinical significance of serum interleukin-17 levels in colorectal cancer patients
KARABULUT S., Afsar C. U., Karabulut M., Kilic L., Alis H., Kones O., et al.
JOURNAL OF BUON
, cilt.21, sa.5, ss.1137-1145, 2016 (SCI-Expanded)
2016
2016Current adjuvant treatment modalities for gastric cancer: From history to the future
Kilic L., Ordu C., Yildiz İ., Sen F., Keskin S., Ciftci R., et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
, cilt.8, sa.5, ss.439-449, 2016 (SCI-Expanded)
2016
2016Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer
TAŞ F., YILDIZ İ., Kilic L., Ciftci R., Keskin S., Sen F.
AMERICAN JOURNAL OF THERAPEUTICS
, cilt.23, sa.3, 2016 (SCI-Expanded)
2016
2016Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma
Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.
JOURNAL OF DERMATOLOGICAL TREATMENT
, cilt.27, sa.3, ss.275-277, 2016 (SCI-Expanded)
2015
2015Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma
Sen F., Yildiz İ., Odabas H., Tambas M., Kilic L., Karadeniz A., et al.
TUMOR BIOLOGY
, cilt.36, sa.2, ss.1039-1044, 2015 (SCI-Expanded)
2015
2015D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients
Kilic L., YILDIZ İ., Sen F. K., Erdem M. G., SERİLMEZ M., Keskin S., et al.
CANCER BIOMARKERS
, cilt.15, sa.4, ss.405-411, 2015 (SCI-Expanded)
2014
2014Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yildiz İ., Varol U., Sen F., Kilic L.
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
, cilt.14, sa.7, ss.654-6, 2014 (SCI-Expanded)
2014
2014The behavior of Turkish cancer patients in fasting during the holy month of Ramadan.
TAŞ F., KARABULUT S., Ciftci R., YILDIZ İ., Keskin S., Kilic L., et al.
Japanese journal of clinical oncology
, cilt.44, sa.8, ss.705-10, 2014 (SCI-Expanded)
2014
2014High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer.
Ciftci R., TAŞ F., TİLGEN YASASEVER C., Aksit E., KARABULUT S., Sen F., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
, cilt.35, sa.7, ss.6941-8, 2014 (SCI-Expanded)
2014
2014Coagulation tests show significant differences in patients with breast cancer
TAŞ F., Kilic L., DURANYILDIZ H. D.
TUMOR BIOLOGY
, cilt.35, sa.6, ss.5985-5992, 2014 (SCI-Expanded)
2014
2014Aspirin resistance in patients with impaired renal functions
Aksu H. U., Oner E., Erturk M., Aksu H., Isiksacan N., Ozalp B., et al.
KARDIOLOGIA POLSKA
, cilt.72, sa.4, ss.331-338, 2014 (SCI-Expanded)
2014
2014Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up
ELİTOK A., Oz F., Cizgici A. Y., Kilic L., Ciftci R., Sen F., et al.
CARDIOLOGY JOURNAL
, cilt.21, sa.5, ss.509-515, 2014 (SCI-Expanded)
2013
2013Age is a prognostic factor affecting survival in lung cancer patients
TAŞ F., Ciftci R., Kilic L., KARABULUT S.
ONCOLOGY LETTERS
, cilt.6, sa.5, ss.1507-1513, 2013 (SCI-Expanded)
2013
2013Performance status of patients is the major prognostic factor at all stages of pancreatic cancer.
TAŞ F., Sen F., Odabas H., Kilic L., Keskin S., YILDIZ İ.
International journal of clinical oncology
, cilt.18, sa.5, ss.839-46, 2013 (SCI-Expanded)
2013
2013Serum M65 as a biomarker for metastatic renal cell carcinoma.
YILDIZ İ., Sen F., Kilic L., Keskin S., DURANYILDIZ H. D., Bilgin E., et al.
Clinical genitourinary cancer
, cilt.11, sa.3, ss.290-6, 2013 (SCI-Expanded)
2013
2013A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer
Yildiz İ., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
, cilt.72, sa.2, ss.437-444, 2013 (SCI-Expanded)
2013
2013Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib.
Sen F., Yildiz İ., Başaran M., Ekenel M., Oz F., Kilic L., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.18, sa.3, ss.775-81, 2013 (SCI-Expanded)
2013
2013Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)
TAŞ F., AYDOĞMUŞ ŞEN F., Keskin S., Kilic L.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
, cilt.27, sa.6, ss.789-792, 2013 (SCI-Expanded)
2013
2013Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).
Keskin S., YILDIZ İ., AYDOĞMUŞ ŞEN F., AYDOĞAN F., Kilic L., EKENEL M., et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
, cilt.15, sa.5, ss.403-8, 2013 (SCI-Expanded)
2013
2013Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.
Aydiner A., Kilic L., Yildiz İ., Keskin S., Sen F., Kucucuk S., et al.
Medical oncology (Northwood, London, England)
, cilt.30, sa.1, ss.354, 2013 (SCI-Expanded)
2013
2013Clinical and prognostic significance of coagulation assays in lung cancer
TAŞ F., Kilic L., SERİLMEZ M., Keskin S., Sen F., DURANYILDIZ H. D.
RESPIRATORY MEDICINE
, cilt.107, sa.3, ss.451-457, 2013 (SCI-Expanded)
2013
2013Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.
TAŞ F., Kilic L., Bilgin E., Keskin S., Sen F., Ciftci R., et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
, cilt.23, sa.2, ss.276-81, 2013 (SCI-Expanded)
2013
2013Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?
AYDINER A., Ciftci R., KARABULUT S., Kilic L.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.14, sa.10, ss.6109-6114, 2013 (SCI-Expanded)
2013
2013Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy.
Aykan N. F., Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., et al.
Medical oncology (Northwood, London, England)
, cilt.30, sa.3, ss.679, 2013 (SCI-Expanded)
2013
2013Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?
Kilic L., Ordu C., EKENEL M., YILDIZ İ., Keskin S., Sen F., et al.
Medical oncology (Northwood, London, England)
, cilt.30, sa.3, ss.660, 2013 (SCI-Expanded)
2012
2012Clinical and prognostic significance of coagulation assays in melanoma.
TAŞ F., Ciftci R., Kilic L., Bilgin E., Keskin S., Sen F., et al.
Melanoma research
, cilt.22, sa.5, ss.368-75, 2012 (SCI-Expanded)
2012
2012The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels
ŞANLI Y., KUYUMCU S., ÖZKAN Z. G., Kilic L., Balik E., TÜRKMEN C., et al.
ANNALS OF NUCLEAR MEDICINE
, cilt.26, sa.7, ss.551-558, 2012 (SCI-Expanded)
2011
2011Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
TAŞ F., Keskin S., Karadeniz A., Dagoglu N., Sen F., Kilic L., et al.
Oncology
, cilt.81, sa.5-6, ss.353-8, 2011 (SCI-Expanded)
2011
2011Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.
Yildiz İ., Sen F., Tuncer S., Kilic L., Basaran M., Bavbek S.
Onkologie
, cilt.34, sa.11, ss.630-3, 2011 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
2023
2023False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status
Avdan Aslan A., Erdemli S., ERDOĞDU İ. H., Gultekin S., URAS C., Tokat F., et al.
ACTA ONCOLOGICA TURCICA
, cilt.56, sa.2, ss.97-105, 2023 (Hakemli Dergi)
2023
2023The technical details of robotic-assisted mitral valve replacement
GÜLLÜ A. Ü., SENAY S., Ersin E., KOÇYİĞİT M., OZER L., ÇELİK Ö., et al.
Journal of Visualized Surgery
, cilt.9, 2023 (Scopus)
2023
2023Impact of Professional Seniority on Total Neoadjuvant Treatment Approach for Locally Advanced Rectal Cancer
Şenocak Taşçi E., AYTAÇ E., Ajredini M., Mutlu A. U., YILDIZ İ., OZER L.
Journal of Oncological Science
, cilt.9, sa.2, ss.89-96, 2023 (Scopus)
2020
2020The Youngest Patient with Metastatic Leiomyosarcoma of the Pancreas.
Saka D., Şişman G., Özer L., Şahin D., Ceyhan G.
Journal of gastrointestinal cancer
, cilt.51, ss.722-723, 2020 (ESCI)
2016
2016Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma
KARABULUT S., Afsar Ç. U., Karabulut M., Alış H., Kılıc L., Çikot M., et al.
Journal of Gastrointestinal Cancer
, cilt.47, sa.1, ss.47-54, 2016 (Scopus)
2014
2014The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
Eralp Y., Kilic L., Alco G., BAŞARAN G., Dogan M., Dincol D., et al.
JOURNAL OF BREAST HEALTH
, cilt.10, sa.4, ss.209-215, 2014 (ESCI)
2014
2014Intolerance to sunitinib treatment in hemodialysis patients with metastatic renal cell carcinoma.
YILDIZ İ., Sen F., Kilic L., Ciftci R., BAŞARAN M.
Korean journal of urology
, cilt.55, sa.1, ss.74-6, 2014 (Hakemli Dergi)
2013
2013Clinical and prognostic significance of coagulation assays in gastric cancer
TAŞ F., Ciftci R., Kilic L., SERİLMEZ M., KARABULUT S., Duranyildiz D.
Journal of Gastrointestinal Cancer
, cilt.44, sa.3, ss.285-292, 2013 (Scopus)
2013
2013Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.
TAŞ F., Sen F., Keskin S., Kilic L., YILDIZ İ.
Molecular and clinical oncology
, cilt.1, sa.4, ss.788-792, 2013 (Hakemli Dergi)
2013
2013Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma
TAŞ F., KARABULUT S., Bilgin E., Kılıc L., Ciftci R., Duranyildiz D.
Journal of Gastrointestinal Cancer
, cilt.44, sa.4, ss.404-409, 2013 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2022
2022Karaciğer Metastazı Olan Evre IV Kolorektal Kanser Hastalarının Küratif Tedavisinin Planlanmasında Multidisipliner Tümör Konseyi Kararlarının Etkisi
Cakcak İ. E., Aytaç E., Özben V., Özer L., Yıldız İ., Gönenç M., et al.
22. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 23 - 27 Mart 2022, ss.10, (Özet Bildiri)
2021
2021Positive MRI findings in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy
Erdemli S., Taşkın F., Erdoğdu İ. H., Tokat F., Behzatoğlu K., Meydan N., et al.
European Congress of Radiology, Vienna, Avusturya, 3 - 07 Mart 2021, ss.164-165, (Özet Bildiri)
2019
2019Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDI-1 expression in Turkish patients with gastric cancer.
Yildiz İ., Bahsi S., Erdamar S., Goksel S., Demir G., Er Ö., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)
2015
2015Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.
Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
2014Distribution and frequency of BRCA gene mutations in Turkish population including Balkan Turks
Akdeniz D., Tuncer B. S., Kilic S., Sukruoglu O., Kilic L., Altundag K., et al.
AACR Special Conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, California, Amerika Birleşik Devletleri, 29 Ocak - 01 Şubat 2014, cilt.74, (Özet Bildiri)
2014
2014Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.
Ciftci R., TAŞ F., Aksit E., VATANSEVER S., KARABULUT S., Sen F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
2014Serum inflammatory parameters as prognostic factors in patients with gastic cancer: Is serum albumin the best inflammotory biomarker predicting prognosis?
Sen F., Zobaci E., Erdemli H. K., Kocabas R., Kilic L., Ylidiz I.
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
2014Clinical and pathologic characteristics of ovarian cancer patients with BRCA1 and BRCA2 mutations in Turkish population
SAİP P. M., Akdeniz B., Tuncer B., Kilic S., Sukruoglu O., Altundag K., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
2014Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma
KARABULUT S., Aykan N. F., Yildiz İ., Kilic L., Sen F., VATANSEVER S.
Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 16 - 18 Ocak 2014, cilt.32, (Özet Bildiri)
2013
2013Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy
Yildiz İ., Sen F., Kilic L., Keskin S., Ciftci R., EKENEL M., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
2013Is there any prognostic importance of pretreatment serum M30 and serum M65 levels on progression-free survival of patients with metastatic renal cell carcinoma treated with first-line sunitinib?
BAŞARAN M., Yildiz İ., Sen F., Kilic L., Keskin S., Darendeliler E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
2013Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.
Ciftci R., Keskin S., KARABULUT S., Yildiz İ., Kilic L., Sen F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
2013Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.
KARABULUT S., Kilic L., Ciftci R., Yildiz İ., Sen F., Keskin S., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
2013Berrak Hücreli Sarkom Bir olgu nedeniyle
GÜRAL Z., OSKEROĞLU S., ERGÜN S., KILIÇ L., AKGÜN Z., YÜCEL S., et al.
20. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2013
Kitaplar
2019
2019ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER
Ozer L., Aydıner A.
BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , ADNAN AYDINER,ATILLA SORAN,ABDULLAH IGCI, Editör, Springer, London/Berlin , Geneve, ss.357-383, 2019
Etkinlik Organizasyonlarındaki Görevler
Nisan 2024
Nisan 2024Advances in gastrointestinal cancer care
Bilimsel Kongre / Sempozyum Organizasyonu
Aytaç E., Ozer L.
İstanbul, Türkiye
Kongre ve Sempozyum Katılımı Faaliyetleri
16 Şubat 2024 - 16 Şubat 2024
16 Şubat 2024 - 16 Şubat 2024WEBTARGED
Davetli Konuşmacı
İstanbul-Türkiye
17 Mart 2023 - 19 Mart 2023
17 Mart 2023 - 19 Mart 2023AVOD ONKOLOJİ GÜNLERİ
Davetli Konuşmacı
Eskişehir-Türkiye
25 Mayıs 2022 - 25 Mayıs 2022
25 Mayıs 2022 - 25 Mayıs 2022Webtarged
Davetli Konuşmacı
İstanbul-Türkiye
18 Mayıs 2022 - 22 Mayıs 2022
18 Mayıs 2022 - 22 Mayıs 2022
Türk Tıbbi Onkoloji Kongresi
Davetli Konuşmacı
Girne-Kıbrıs (Kktc)
14 Mayıs 2022 - 14 Mayıs 2022
14 Mayıs 2022 - 14 Mayıs 2022Bİyobelirteçler Ve Onkolojik Tedaviler Sempozyumu
Davetli Konuşmacı
İstanbul-Türkiye
21 Nisan 2022 - 24 Nisan 2022
21 Nisan 2022 - 24 Nisan 2022
Hedef Kanser 2022
Davetli Konuşmacı
Girne-Kıbrıs (Kktc)
15 Ocak 2022 - 16 Ocak 2022
15 Ocak 2022 - 16 Ocak 2022
On Targed Master Oncology
Davetli Konuşmacı
Antalya-Türkiye
26 Ekim 2021 - 27 Ekim 2021
26 Ekim 2021 - 27 Ekim 2021
Immunooncology Network Meeting
Davetli Konuşmacı
İstanbul-Türkiye
07 Ekim 2021 - 10 Ekim 2021
07 Ekim 2021 - 10 Ekim 2021ulusal akciğer sağlığı kongresi
Davetli Konuşmacı
Antalya-Türkiye
18 Haziran 2021 - 20 Haziran 2021
18 Haziran 2021 - 20 Haziran 2021Kanserde İmmünoonkolojik ve Moleküler Onkolojik tedaviler Kursu
Davetli Konuşmacı
İstanbul-Türkiye
21 Mayıs 2021 - 23 Mayıs 2021
21 Mayıs 2021 - 23 Mayıs 2021